Skip to content

Human application study to confirm the skin health improvement effect and safety of Chlorella

Human application study to confirm the skin health improvement effect and safety of Chlorella

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007205
Enrollment
100
Registered
2022-04-18
Start date
2022-03-21
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Applicants who voluntarily signed the consent form for human application study on visit 1(-2 weeks) will be judged for suitability according to the selection and exclusion criteri

Sponsors

Global Medical Research Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) A person who has consented to participate in this study and signed a written consent form. 2) Adults aged 30 to under 60 years old. 3) Those who have dry skin (Cornometer®CM825 measured moisture content index of 49 or less), have begun to produce wrinkles around their eyes, or have already produced them (visual evaluation grade 3 or more)

Exclusion criteria

Exclusion criteria: Those who meet the conditions described below are excluded. 1) Those who have abnormal skin conditions such as moles, acne, erythema, and capillaries. 2) Those who are currently suffering from or undergoing treatment for skin diseases such as atopic dermatitis and psoriasis. 3) Those who take oral contraceptives, hormones, diuretics, and immune drugs. 4) Users of oral medications containing steroids or retinoids and skin external applications containing the ingredients within 3 months of their first visit. 5) Users of functional cosmetics (retinoid agent, retinol, AHA) or high-humidification cosmetics to improve wrinkles within 2 weeks of their first visit. 6) A person who have undergone skin exfoliation, laser, chemical peeling, and other skin care procedures on the face within one month of his first visit, or Botox and filler procedures on the face within six months. 7) Patients with diseases such as uncontrolled hypertension, uncontrolled diabetes mellitus, renal dysfunction, and liver dysfunction. 8) Those who continue to eat health functional foods within a month of their first visit. 9) Smokers or those who have smoked for less than 1 year. 10) Participants in other clinical studies within 1 month of their first visit (within 6 months for clinical studies related to skin health) 11) Pregnant or lactating women, those who plan to become pregnant. 12) Those who have hypersensitivity to test/control food or its ingredients, or have experienced severe food allergy reactions. 13) Those who are judged inappropriate by the researcher to participate in this study.

Design outcomes

Primary

MeasureTime frame
Skin moisture, percutaneous moisture loss, dead skin cell, skin elasticity, skin texture, wrinkles around the eyes, skin luster, moisture in the skin, overall improvement

Secondary

MeasureTime frame
Clinical pathology test(blood, urine);Vital signs;Adverse event

Countries

Korea, Republic of

Contacts

Public ContactJuhee Lee

Yonsei University Health System, Severance Hospital

juhee@yuhs.ac+82-2-2228-2082

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026